Public Profile

Telesis Bio, Inc.

Telesis Bio, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in advanced DNA synthesis and genomic technologies. Founded in 2020, Telesis Bio has quickly established itself as a leader in the field, focusing on innovative solutions that enhance synthetic biology applications. The company’s flagship products, including the BioXp™ system, offer unique capabilities for rapid and scalable DNA synthesis, catering to a diverse range of industries such as pharmaceuticals, agriculture, and synthetic biology research. Telesis Bio's commitment to quality and efficiency has positioned it as a key player in the market, driving significant advancements in genetic engineering and molecular biology. With a strong emphasis on innovation, Telesis Bio continues to shape the future of biotechnology.

DitchCarbon Score

How does Telesis Bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

4

Industry Benchmark

Telesis Bio, Inc.'s score of 18 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Telesis Bio, Inc.'s reported carbon emissions

Telesis Bio, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is challenging to assess their carbon footprint or climate strategy. However, the company operates within an industry increasingly focused on sustainability and reducing greenhouse gas emissions. As such, Telesis Bio may be expected to align with broader industry trends towards carbon neutrality and responsible environmental practices in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Telesis Bio, Inc.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Telesis Bio, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Telesis Bio, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Integrated DNA Technologies, Inc.

US
Health and social work services (85)
Updated 6 days ago
DitchCarbon Score

Aldevron, LLC

US
Research and development services (73)
Updated 6 days ago

Eurofins Scientific

LU
Other business services (74)
Updated 3 days ago

Synthego Corporation

US
Computer and related services (72)
Updated 3 days ago

Chemtreat

US
Chemicals nec
Updated 1 day ago

Azenta Life Science

US
Health and social work services (85)
Updated about 15 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers